Genetics of Headache

  • Chapter
Pathophysiology of Headaches

Part of the book series: Headache ((HEAD))

Abstract

Migraine is an episodic brain disorder with disabling attacks of headache that are associated with nausea, vomiting, and hypersensitivity to light, sound, and smell. Clinically, migraine is divided into two main subtypes that are based on the absence (migraine without aura, MO) or presence (migraine with aura, MA) of an aura. The importance of genetic determinants in migraine is well established. The prototype of monogenic forms of migraine is familial hemiplegic migraine (FHM), a rare condition for which three causative genes have been identified. Studies of transgenic animal models have substantially improved our understanding of the molecular pathophysiology of FHM and helped to understand the mechanisms of aura in migraine in general. Beyond this, there are other (rarer) syndromic forms of migraine, e.g., MELAS and CADASIL. By contrast, the more common types of migraine with and without aura are genetically complex and identification of robust genetic risk variants in transnational genome-wide association studies (GWAS) has substantially increased our knowledge in this expanding field. We will summarize the current status of migraine genetics, with a special focus on FHM and the most recent findings in GWAS.Current studies in pharmacogenomics as a contribution to improve treatment options in individual patients and the future landscape of sequence methodologies in migraine are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 67.40
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 85.59
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 106.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808

    Article  Google Scholar 

  2. Peng KP, Wang SJ (2014) Epidemiology of headache disorders in the Asia-pacific region. Headache 54:610–618

    Article  PubMed  Google Scholar 

  3. Stewart WF, Roy J, Lipton RB (2013) Migraine prevalence, socioeconomic status, and social causation. Neurology 81:948–955

    Article  PubMed Central  PubMed  Google Scholar 

  4. Bigal ME, Lipton RB (2009) The epidemiology, burden, and comorbidities of migraine. Neurol Clin 27:321–334

    Article  PubMed  Google Scholar 

  5. Buse DC, Loder EW, Gorman JA, Stewart WF, Reed ML, Fanning KM, Serrano D, Lipton RB (2013) Sex differences in the prevalence, symptoms, and associated features of migraine, probable migraine and other severe headache: results of the American Migraine Prevalence and Prevention (AMPP) Study. Headache 53:1278–1299

    Article  PubMed  Google Scholar 

  6. D’Amico D, Tepper SJ (2008) Prophylaxis of migraine: general principles and patient acceptance. Neuropsychiatr Dis Treat 4:1155–1167

    Article  PubMed Central  PubMed  Google Scholar 

  7. World Health Organization. World Health Report 2001: mental health: new understanding, new hope. Accessed: http://www.who.int/whr/2001/en/index.html. Accessed: 20/05/2012

  8. Scher AI, Bigal ME, Lipton RB (2005) Comorbidity of migraine. Curr Opin Neurol 18:305–310

    Article  PubMed  Google Scholar 

  9. Lauritzen M (1994) Pathophysiology of the migraine aura. The spreading depression theory. Brain 117:199–210

    Article  PubMed  Google Scholar 

  10. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischl B, Kwong KK, Cutrer FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA (2001) Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 98:4687–4692

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Noseda R, Burstein R (2013) Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain 54(Suppl 1):1–21

    Google Scholar 

  12. Schürks M (2012) Genetics of migraine in the age of genome-wide association studies. J Headache Pain 13:1–9

    Article  PubMed Central  PubMed  Google Scholar 

  13. Magis D, Schoenen J (2012) Migraine: from genetics to environment. Rev Med Liege 67:349–358

    CAS  PubMed  Google Scholar 

  14. Colson N, Fernandez F, Griffiths L (2010) Genetics of menstrual migraine: the molecular evidence. Curr Pain Headache Rep 14:389–395

    Article  PubMed  Google Scholar 

  15. Russell MB, Olesen J (1995) Increased familial risk and evidence of genetic factor in migraine. Br Med J 311:541–544

    Article  CAS  Google Scholar 

  16. Russell MB, Iselius L, Olesen J (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16:305–309

    Article  CAS  PubMed  Google Scholar 

  17. Russell MB, Ulrich V, Gervil M, Olesen J (2002) Migraine without aura and migraine with aura are distinct disorders. A population-based twin survey. Headache 42:332–336

    Article  PubMed  Google Scholar 

  18. Kallela M, Wessman M, Havanka H, Palotie A, Farkkila M (2001) Familial migraine with and without aura: clinical characteristics and co-occurrence. Eur J Neurol 8:441–449

    Article  CAS  PubMed  Google Scholar 

  19. Nyholt DR, Gillespie NG, Heath AC, Merikangas KR, Duffy DL, Martin NG (2004) Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol 26:231–244

    Article  PubMed  Google Scholar 

  20. Ligthart L, Boomsma DI, Martin NG, Stubbe JH, Nyholt DR (2006) Migraine with aura and migraine without aura are not distinct entities: further evidence from a large Dutch population study. Twin Res Hum Genet 9:54–63

    Article  PubMed  Google Scholar 

  21. Thomsen LL, Eriksen MK, Roemer SF, Andersen I, Olesen J, Russell MB (2002) A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria. Brain 125:1379–1391

    Article  CAS  PubMed  Google Scholar 

  22. Thomsen LL, Ostergaard E, Olesen J, Russell MB (2003) Evidence for a separate type of migraine with aura: sporadic hemiplegic migraine. Neurology 60:595–601

    Article  PubMed  Google Scholar 

  23. Ophoff RA, Terwindt GM, Vergouwe MN, van Eijk R, Oefner PJ, Hoffman SM, Lamerdin JE, Mohrenweiser HW, Bulman DE, Ferrari M, Haan J, Lindhout D, van Ommen GJ, Hofker MH, Ferrari MD, Frants RR (1996) Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 87:543–552

    Article  CAS  PubMed  Google Scholar 

  24. Catterall WA (1998) Structure and function of neuronal Ca2+ channels and their role in neurotransmitter release. Cell Calcium 24:307–323

    Article  CAS  PubMed  Google Scholar 

  25. de Vries B, Frants RR, Ferrari MD, van den Maagdenberg AM (2009) Molecular genetics of migraine. Hum Genet 126:115–132

    Article  CAS  PubMed  Google Scholar 

  26. Joutel A, Bousser MG, Biousse V, Labauge P, Chabriat H, Nibbio A, Maciazek J, Meyer B, Bach MA, Weissenbach J (1993) A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet 5:40–45

    Article  CAS  PubMed  Google Scholar 

  27. De Fusco M, Marconi R, Silvestri L, Atorino L, Rampoldi L, Morgante L, Ballabio A, Aridon P, Casari G (2003) Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 33:192–196

    Article  PubMed  Google Scholar 

  28. Riant F, De Fusco M, Aridon P, Ducros A, Ploton C, Marchelli F, Maciazek J, Bousser MG, Casari G, Tournier-Lasserve E (2005) ATP1A2 mutations in 11 families with familial hemiplegic migraine. Hum Mutat 26:281

    Article  PubMed  Google Scholar 

  29. Vanmolkot KR, Kors EE, Turk U, Turkdogan D, Keyser A, Broos LA, Kia SK, van den Heuvel JJ, Black DF, Haan J, Frants RR, Barone V, Ferrari MD, Casari G, Koenderink JB, van den Maagdenberg AM (2006) Two de novo mutations in the Na, K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine. Eur J Hum Genet 14:555–560

    Article  CAS  PubMed  Google Scholar 

  30. Spadaro M, Ursu S, Lehmann-Horn F, Veneziano L, Antonini G, Giunti P, Frontali M, Jurkat-Rott K (2004) A G301R Na+/K+-Atpase mutation causes familial hemiplegic migraine type 2 with cerebellar signs. Neurogenetics 5:177–185

    Article  CAS  PubMed  Google Scholar 

  31. Echenne B, Ducros A, Rivier F, Joutel A, Humbertclaude V, Roubertie A, Azaïs M, Bousser MG, Tournier-Lasserve E (1999) Recurrent episodes of coma: an unusual phenotype of familial hemiplegic migraine with linkage to chromosome 1. Neuropediatrics 30:214–217

    Article  CAS  PubMed  Google Scholar 

  32. Jurkat-Rott K, Freilinger T, Dreier JP, Herzog J, Göbel H, Petzold GC, Montagna P, Gasser T, Lehmann-Horn F, Dichgans M (2004) Variability of familial hemiplegic migraine with novel A1A2 Na+/K+−ATPase variants. Neurology 62:1857–1861

    Article  CAS  PubMed  Google Scholar 

  33. Dichgans M, Freilinger T, Eckstein G, Babini E, Lorenz-Depiereux B, Biskup S, Ferrari MD, Herzog J, van den Maagdenberg AM, Pusch M, Strom TM (2005) Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366:371–377

    Article  CAS  PubMed  Google Scholar 

  34. Parihar R, Ganesh S (2013) The SCN1A gene variants and epileptic encephalopathies. J Hum Genet 58:573–580

    Article  CAS  PubMed  Google Scholar 

  35. Vahedi K, Depienne C, Le Fort D, Riant F, Chaine P, Trouillard O, Gaudric A, Morris MA, Leguern E, Tournier-Lasserve E, Bousser MG (2009) Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. Neurology 72:1178–1183

    Article  CAS  PubMed  Google Scholar 

  36. Riant F, Roze E, Barbance C, Méneret A, Guyant-Maréchal L, Lucas C, Sabouraud P, Trébuchon A, Depienne C, Tournier-Lasserve E (2012) PRRT2 mutations cause hemiplegic migraine. Neurology 79:2122–2124

    Article  CAS  PubMed  Google Scholar 

  37. Pelzer N, de Vries B, Kamphorst JT, Vijfhuizen LS, Ferrari MD, Haan J, van den Maagdenberg AM, Terwindt GM (2014) PRRT2 and hemiplegic migraine: a complex association. Neurology 83:288–290

    Article  PubMed  Google Scholar 

  38. Pietrobon D (2010) Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine. J Physiol 588:1871–1878

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Tavraz NN, Friedrich T, Durr KL, Koenderink JB, Bamberg E, Freilinger T, Dichgans M (2008) Diverse functional consequences of mutations in the Na+/K+ −ATPase alpha2-subunit causing familial hemiplegic migraine type 2. J Biol Chem 283:31097–31106

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  40. van den Maagdenberg AM, Pietrobon D, Pizzorusso T, Kaja S, Broos LAM, Cesetti T, van de Ven RCG, Tottene A, van der Kaa J, Plomp JJ, Frants RR, Ferrari MD (2004) A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 41:701–710

    Article  PubMed  Google Scholar 

  41. van den Maagdenberg AM, Pizzorusso T, Kaja S, Terpolilli N, Shapovalova M, Hoebeek FE, Barrett CF, Gherardini L, van de Ven RCG, Todorov B, Broos LAM, Tottene A, Gao Z, Fodor M, de Zeeuw CI, Frants RR, Plesnila N, Plomp JJ, Pietrobon D, Ferrari MD (2010) High cortical spreading depression susceptibility and migraine-associated symptoms in CaV2.1 S218L mice. Ann Neurol 67:85–98

    Article  PubMed  Google Scholar 

  42. Stam AH, Luijckx GJ, Poll-The BT, Ginjaar IB, Frants RR, Haan J, Ferrari MD, Terwindt GM, van den Maagdenberg AM (2009) Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation. J Neurol Neurosurg Psychiatry 80:1125–1129

    Article  CAS  PubMed  Google Scholar 

  43. Chanda ML, Tuttle AH, Baran I, Atlin C, Guindi D, Hathaway G, Israelian N, Levenstadt J, Low D, Macrae L, O’Shea L, Silver A, Zendegui E, Mariette Lenselink A, Spijker S, Ferrari MD, van den Maagdenberg AM, Mogil JS (2013) Behavioral evidence for photophobia and stress-related ipsilateral head pain in transgenic Cacna1a mutant mice. Pain 154:1254–1262

    Article  PubMed  Google Scholar 

  44. Eikermann-Haerter K, Dileköz E, Kudo C, Savitz SI, Waeber C, Baum MJ, Ferrari MD, van den Maagdenberg AM, Moskowitz MA, Ayata C (2009) Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1. J Clin Invest 119:99–109

    PubMed Central  CAS  PubMed  Google Scholar 

  45. Tottene A, Conti R, Fabbro A, Vecchia D, Shapovalova M, Santello M, van den Maagdenberg AM, Ferrari MD, Pietrobon D (2009) Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in CaV2.1 knockin migraine mice. Neuron 61:762–773

    Article  CAS  PubMed  Google Scholar 

  46. Leo L, Gherardini L, Barone V, De Fusco M, Pietrobon D, Pizzorusso T, Casari G (2011) Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2. PLoS Genet 7(6):e1002129

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. James PF, Grupp IL, Grupp G, Woo AL, Askew GR, Croyle ML, Walsh RA, Lingrel JB (1999) Identification of a specific role for the Na, K-ATPase alpha 2 isoform as a regulator of calcium in the heart. Mol Cell 3:555–563

    Article  CAS  PubMed  Google Scholar 

  48. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, Takeuchi T, Itohara S, Yanegawa Y, Obata K, Furuichi T, Hensch TK, Yamakawa K (2007) NaV1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 27:5903–5914

    Article  CAS  PubMed  Google Scholar 

  49. Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F (1988) MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 38:751–754

    Article  CAS  PubMed  Google Scholar 

  50. Dichgans M, Mayer M, Uttner I, Bruning R, Muller-Hocker J, Rungger G, Ebke M, Klockgether T, Gasser T (1998) The phenotypic spectrum of CADASIL: clinical findings in 102 cases. Ann Neurol 44:731–739

    Article  CAS  PubMed  Google Scholar 

  51. Richards A, van den Maagdenberg AM, Jen JC, Kavanagh D, Bertram P, Spitzer D, Liszewski MK, Barilla-Labarca ML, Terwindt GM, Kasai Y, McLellan M, Grand MG, Vanmolkot KR, de Vries B, Wan J, Kane MJ, Mamsa H, Schäfer R, Stam AH, Haan J, de Jong PT, Storimans CW, van Schooneveld MJ, Oosterhuis JA, Gschwendter A, Dichgans M, Kotschet KE, Hodgkinson S, Hardy TA, Delatycki MB, Hajj-Ali RA, Kothari PH, Nelson SF, Frants RR, Baloh RW, Ferrari MD, Atkinson JP (2007) C-terminal truncations in human 3′–5′ DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nat Genet 39:1068–1070

    Article  CAS  PubMed  Google Scholar 

  52. Feuerhake F, Volk B, Ostertag CB, Jungling FD, Kassubek J, Orszagh M, Dichgans M (2002) Reversible coma with raised intracranial pressure: an unusual clinical manifestation of CADASIL. Acta Neuropathol 103:188–192

    Article  CAS  PubMed  Google Scholar 

  53. Sicurelli F, Dotti MT, De Stefano N, Malandrini A, Mondelli M, Bianchi S, Federico A (2005) Peripheral neuropathy in CADASIL. J Neurol 252:1206–1209

    Article  PubMed  Google Scholar 

  54. Haritoglou C, Rudolph G, Hoops JP, Opherk C, Kampik A, Dichgans M (2004) Retinal vascular abnormalities in CADASIL. Neurology 62:1202–1205

    Article  CAS  PubMed  Google Scholar 

  55. Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Marechal E, Maciazek J, Vayssiere C, Cruaud C, Cabanis EA, Ruchoux MM, Weissenbach J, Bach JF, Bousser M-G, Tournier-Lasserve E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710

    Article  CAS  PubMed  Google Scholar 

  56. Yamamoto Y, Craggs L, Baumann M, Kalimo H, Kalaria RN (2011) Review: molecular genetics and pathology of hereditary small vessel diseases of the brain. Neuropathol Appl Neurobiol 37:94–113

    Article  CAS  PubMed  Google Scholar 

  57. Eikermann-Haerter K, Yuzawa I, Dileköz E, Joutel A, Moskowitz MA, Ayata C (2011) Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy syndrome mutations increase susceptibility to spreading depression. Ann Neurol 69:413–418

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Grand MG, Kaine J, Fulling K, Atkinson J, Dowton SB, Farber M, Craver J, Rice K (1988) Cerebroretinal vasculopathy. A new hereditary syndrome. Ophthalmology 95:649–659

    Article  CAS  PubMed  Google Scholar 

  59. Jen J, Cohen AH, Yue Q, Stout JT, Vinters HV, Nelson S, Baloh RW (1997) Hereditary endotheliopathy with retinopathy, nephropathy, and stroke (HERNS). Neurology 49:1322–1330

    Article  CAS  PubMed  Google Scholar 

  60. Terwindt GM, Haan J, Ophoff RA, Groenen SM, Storimans CW, Lanser JB, Roos RA, Bleeker-Wagemakers EM, Frants RR, Ferrari MD (1998) Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud’s phenomenon. Brain 121:303–316

    Article  PubMed  Google Scholar 

  61. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP (1984) Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol 16:481–488

    Article  CAS  PubMed  Google Scholar 

  62. Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133–158

    Article  CAS  PubMed  Google Scholar 

  63. Mancuso M, Filosto M, Mootha VK, Rocchi A, Pistolesi S, Murri L, DiMauro S, Siciliano G (2004) A novel mitochondrial tRNAPhe mutation causes MERRF syndrome. Neurology 62:2119–2121

    Article  CAS  PubMed  Google Scholar 

  64. Melone MA, Tessa A, Petrini S, Lus G, Sampaolo S, di Fede G, Santorelli FM, Cotrufo R (2004) Revelation of a new mitochondrial DNA mutation (G12147A) in a MELAS/MERFF phenotype. Arch Neurol 61:269–272

    Article  PubMed  Google Scholar 

  65. Malkov A, Ivanov AI, Popova I, Mukhtarov M, Gubkina O, Waseem T, Bregestovski P, Zilberter Y (2014) Reactive oxygen species initiate a metabolic collapse in hippocampal slices: potential trigger of cortical spreading depression. J Cereb Blood Flow Metab 34:1540–1549

    Article  CAS  PubMed  Google Scholar 

  66. Lafrenière RG, Cader MZ, Poulin J-F, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafrenière F, Mclaughlan S, Dubé M-P, Marcinkiewicz MM, Ramagopalan S, Ansorge O, Brais B, Sequeiros J, Pereira-Monteiro JM, Griffiths LR, Tucker SJ, Ebers G, Rouleau GA (2010) A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med 16:1157–1160

    Article  PubMed  Google Scholar 

  67. Andres-Enguix I, Shang L, Stansfeld PJ, Morahan JM, Sansom MSP, Lafrenière RG, Roy B, Griffiths LR, Rouleau GA, Ebers GC, Cader ZM, Tucker SJ (2012) Functional analysis of missense variants in the TRESK (KCNK18) K channel. Sci Rep 2:237

    Article  PubMed Central  PubMed  Google Scholar 

  68. Anttila V, Stefansson H, Kallela M, Todt U, Terwindt GM, Calafato MS, Nyholt DR, Dimas AS, Freilinger T, Müller-Myhsok B, Artto V, Inouye M, Alakurtti K, Kaunisto MA, Hämäläinen E, de Vries B, Stam AH, Weller CM, Heinze A, Heinze-Kuhn K, Goebel I, Borck G, Göbel H, Steinberg S, Wolf C, Björnsson A, Gudmundsson G, Kirchmann M, Hauge A, Werge T, Schoenen J, Eriksson JG, Hagen K, Stovner L, Wichmann H-E, Meitinger T, Alexander M, Moebus S, Schreiber S, Aulchenko YS, Breteler MMB, Uitterlinden AG, Hofman A, van Duijn CM, Tikka-Kleemola P, Vepsäläinen S, Lucae S, Tozzi F, Muglia P, Barrett J, Kaprio J, Färkkilä M, Peltonen L, Stefansson K, Zwart J-A, Ferrari MD, Olesen J, Daly M, Wessman M, van den Maagdenberg AM, Dichgans M, Kubisch C, Dermitzakis ET, Frants RR, Palotie A, International Headache Genetics Consortium (2010) Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet 42:869–873

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Chasman DI, Schürks M, Anttila V, de Vries B, Schminke U, Launer LJ, Terwindt GM, van den Maagdenberg AMJM, Fendrich K, Völzke H, Ernst F, Griffiths LR, Buring JE, Kallela M, Freilinger T, Kubisch C, Ridker PM, Palotie A, Ferrari MD, Hoffmann W, Zee RYL, Kurth T (2011) Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat Genet 43:695–698

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  70. Freilinger T, Anttila V, de Vries B, Malik R, Kallela M, Terwindt GM, Pozo-Rosich P, Winsvold B, Nyholt DR, van Oosterhout WPJ, Artto V, Todt U, Hämäläinen E, Fernández-Morales J, Louter MA, Kaunisto MA, Schoenen J, Raitakari O, Lehtimäki T, Vila-Pueyo M, Göbel H, Wichmann E, Sintas C, Uitterlinden AG, Hofman A, Rivadeneira F, Heinze A, Tronvik E, van Duijn CM, Kaprio J, Cormand B, Wessman M, Frants RR, Meitinger T, Müller-Myhsok B, Zwart J-A, Färkkilä M, Macaya A, Ferrari MD, Kubisch C, Palotie A, Dichgans M, van den Maagdenberg AM, International Headache Genetics Consortium (2012) Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 44:777–782

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Anttila V, Winsvold BS, Gormley P, Kurth T, Bettella F, McMahon G, Kallela M, Malik R, de Vries B, Terwindt G, Medland SE, Todt U, McArdle WL, Quaye L, Koiranen M, Ikram MA, Lehtimäki T, Stam AH, Ligthart L, Wedenoja J, Dunham I, Neale BM, Palta P, Hämäläinen E, Schürks M, Rose LM, Buring JE, Ridker PM, Steinberg S, Stefansson H, Jakobsson F, Lawlor DA, Evans DM, Ring SM, Färkkilä M, Artto V, Kaunisto MA, Freilinger T, Schoenen J, Frants RR, Pelzer N, Weller CM, Zielman R, Heath AC, Madden PAF, Montgomery GW, Martin NG, Borck G, Göbel H, Heinze A, Heinze-Kuhn K, Williams FMK, Hartikainen A-L, Pouta A, van den Ende J, Uitterlinden AG, Hofman A, Amin N, Hottenga J-J, Vink JM, Heikkilä K, Alexander M, Müller-Myhsok B, Schreiber S, Meitinger T, Wichmann HE, Aromaa A, Eriksson JG, Traynor BJ, Trabzuni D, Rossin E, Lage K, Jacobs SBR, Gibbs JR, Birney E, Kaprio J, Penninx BW, Boomsma DI, van Duijn C, Raitakari O, Järvelin M-R, Zwart J-A, Cherkas L, Strachan DP, Kubisch C, Ferrari MD, van den Maagdenberg AM, Dichgans M, Wessman M, Smith GD, Stefansson K, Daly MJ, Nyholt DR, Chasman DI, Palotie A, North American Brain Expression Consortium, UK Brain Expression Consortium, North American Brain Expression Consortium, UK Brain Expression Consortium, International Headache Genetics Consortium (2013) Genome-wide meta-analysis identifies new susceptibility loci for migraine. Nat Genet 45:912–917

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Luykx J, Mason M, Ferrari MD, Carpay J (2009) Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine. Clin Pharmacol Ther 85:283–288

    Article  CAS  PubMed  Google Scholar 

  73. Viana M, Terrazzino S, Genazzani AA, Grieco GS, Cargnin S, Santorelli FM, Pierelli F, Tassorelli C, Nappi G, Di Lorenzo C (2014) Pharmacogenomics of episodic migraine: time has come for a step forward. Pharmacogenomics 15:541–549

    Article  CAS  PubMed  Google Scholar 

  74. Ishii M, Sakairi Y, Hara H, Imagawa A, Shimizu S, Takahashi J, Nagamine A, Naito Y, Masuda Y, Usami S, Kiuchi Y (2012) Negative predictors of clinical response to triptans in patients with migraine. Neurol Sci 33:453–461

    Article  CAS  PubMed  Google Scholar 

  75. Terrazzino S, Viana M, Floriddia E, Monaco F, Mittino D, Sances G, Tassorelli C, Nappi G, Rinaldi M, Canonico PL, Genazzani AA (2010) The serotonin transporter gene polymorphism STin2 VNTR confers an increased risk of inconsistent response to triptans in migraine patients. Eur J Pharmacol 641:82–87

    Article  CAS  PubMed  Google Scholar 

  76. Asuni C, Cherchi A, Congiu D, Piccardi MP, Del Zompo M, Stochino ME (2007) Association study between clinical response to rizatriptan and some candidate genes. J Headache Pain 8:185–189

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  77. Ulrich V, Gervil M, Olesen J (2004) The relative influence of environment and genes in episodic tension-type headache. Neurology 62:2065–2069

    Article  PubMed  Google Scholar 

  78. Russell MB, Saltyte-Benth J, Levi N (2006) Are infrequent episodic, frequent episodic and chronic tension-type headache inherited? A population-based study of 11 199 twin pairs. J Head Pain 7:119–126

    Article  Google Scholar 

  79. Russell MB, Andersson PG, Thomsen LL (1995) Familial occurrence of cluster headache. J Neurol Neurosurg Psychiatry 58:341–343

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Russell MB, Andersson PG, Thomsen LL, Iselius L (1995) Cluster headache is an autosomal dominantly inherited disorder in some families: a complex segregation analysis. J Med Genet 32:954–956

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  81. Shimomura T, Kitano A, Marukawa H, Mishima K, Isoe K, Adachi Y, Takahashi K (1994) Point mutation in platelet mitochondrial tRNA Leu(UUR) in patient with cluster headache. Lancet 344:625

    Article  CAS  PubMed  Google Scholar 

  82. Odawara M, Tamaoka A, Mizusawa H, Yamashita K (1997) A case of cluster headache associated with mitochondrial DNA deletions. Muscle Nerve 20:394–395

    CAS  PubMed  Google Scholar 

  83. Cortelli P, Zacchini A, Barboni P, Malpassi P, Carelli V, Montagna P (1995) Lack of association between mitochondrial tRNA (Leu(UUR)) point mutation and cluster headache. Lancet 345:1120–1121

    Article  CAS  PubMed  Google Scholar 

  84. Seibel P, Grünewald T, Gundolla A, Diener HC, Reichmann H (1996) Investigation on the mitochondrial transfer RNA(Leu)(UUR) in blood cells from patients with cluster headache. J Neurol 243:305–307

    Article  CAS  PubMed  Google Scholar 

  85. Rainero I, Gallone S, Valfrè W, Ferrero M, Angilella G, Rivoiro C, Rubino E, De Martino P, Savi L, Ferrone M, Pinessi L (2004) A polymorphism of the hypocretin receptor 2 gene is associated with cluster headache. Neurology 63:1286–1288

    Article  CAS  PubMed  Google Scholar 

  86. Schürks M, Kurth T, Geissler I, Tessmann G, Diener HC, Rosskopf D (2006) Cluster headache is associated with the G1246A polymorphism in the hypocretin receptor 2 gene. Neurology 66:1917–1919

    Article  PubMed  Google Scholar 

  87. Baumber L, Sjöstrand C, Leone M, Harty H, Bussone G, Hillert J, Trembath RC, Russell MB (2006) A genome-wide scan and HCRTR2 candidate gene analysis in a European cluster headache cohort. Neurology 66:1888–1893

    Article  CAS  PubMed  Google Scholar 

  88. Weller CM, Wilbrink LA, Houwing-Duistermaat JJ, Koelewijn SC, Vijfhuizen LS, Haan J, Ferrari MD, Terwindt GM, van den Maagdenberg AM, de Vries B (2014). Cluster headache and the hypocretin receptor 2 reconsidered: a genetic association study and meta-analysis. Cephalalgia. pii: 0333102414557839. [Epub ahead of print]. PubMed PMID: 25398231

    Google Scholar 

  89. Xue Y, Ankala A, Wilcox WR, Hegde MR (2014) Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med. doi:10.1038/gim.2014.122, [Epub ahead of print]. PubMed PMID: 25232854

    PubMed  Google Scholar 

  90. Biesecker LG, Green RC (2014) Diagnostic clinical genome and exome sequencing. N Engl J Med 370:2418–2425

    Article  PubMed  Google Scholar 

  91. Annas GJ, Elias S (2014) 23 and me and the FDA. N Engl J Med 370:2248–2249

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Filippo M. Santorelli or Arn M. J. M. van den Maagdenberg .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Di Lorenzo, C., Santorelli, F.M., van den Maagdenberg, A.M.J.M. (2015). Genetics of Headache. In: Ashina, M., Geppetti, P. (eds) Pathophysiology of Headaches. Headache. Springer, Cham. https://doi.org/10.1007/978-3-319-15621-7_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15621-7_4

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15620-0

  • Online ISBN: 978-3-319-15621-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Navigation